• OpenAccess
    • List of Articles sara arti

      • Open Access Article

        1 - Recombinant lactococcus, a new approach for oral vaccines
        علی شریف زاده sara arti fatemeh shayesteh
        Recombinant probiotics are increasingly acting as carriers for the expression and targeted delivery of recombinant or natural molecules to mucosal surfaces in nutrition and health. Probiotics-mediated delivery systems eliminate the need to purify molecules to a large ex More
        Recombinant probiotics are increasingly acting as carriers for the expression and targeted delivery of recombinant or natural molecules to mucosal surfaces in nutrition and health. Probiotics-mediated delivery systems eliminate the need to purify molecules to a large extent and make it possible to deliver molecules to the mucosa. The concept of biological medicine is the oral administration of living recombinant microorganisms for the prevention or treatment of various diseases. Lactococcus lactis is a gram-positive bacterium from the group of lactic acid bacteria. Lactococcus lactis has been used for centuries in food fermentation, especially cheese, yogurt, sauerkraut and the like. Therefore, it is generally recognized as a safe situation by the Food and Drug Organization. In this review article, review articles related to lactococcus and its wide application in oral vaccine production from 1998 to 2020 were collected. Accordingly, the following databases were searched. Scopus, PubMed and Google Scholar databases. The keywords used in this study included "immunity, Lactococcus lactis and vaccine". Lactococcus lactis is generally recognized as safe and can be widely used in the food industry. Live recombinant Lactococcus lactis, as a biological drug, is administered orally as a live vaccine that expresses viral and bacterial antigens. Manuscript profile